0.25 - 15 mins

Education

Results 1 - 59 of 59

Beyond Routine Recovery: Treating Atypical Postpartum Complications

Diagnosis of Smoldering MS

Limitations of Current Therapeutic Options to Manage MS and Disability Progression

BTK Inhibitor Treatment Options for Smoldering MS

Beyond Preeclampsia: Recognizing and Responding to Rare Complications

Thrombotic Threats in Early Pregnancy: Unraveling Rare Blood Disorders

Module 2: Enhancing NVAF Recognition - Whiteboard Animation

Module 1: Insights Into Advances in NVAF - Animated Case

9256-0002_Thumbnail

Conference Updates in DMD and LGMD (WMS and MDA)

animation-263x149

Encouraging Shared Decision-Making with MS Patients

Advances in the Understanding of MS Immunology, Therapies, & Biomarkers

Individualized Care Plans and Emerging Tools for Patient Monitoring

Identify the Etiology of Aplastic Anemia in Patients

Recognizing Risk and Benefits of Management Options for Aplastic Anemia

Considerations for Special Populations With Aplastic Anemia

01.DMD-VirtueMart5

DMD Micro-Learning Library

Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)

Emerging Treatments in Chronic GvHD

Treatment of Ph+ Relapsed/Refractory ALL

Treatment of Ph- Relapsed/Refractory ALL

Identification of Relapsed ALL

Principles of Management of Chronic GVHD

Diagnosing and Assessing Chronic Graft-versus-Host Disease

SSc-ILD Individualized Treatment

Multidisciplinary Management of IPF

Fundamentals of Diagnosis: SSc-ILD

Fundamentals of Diagnosis: PF-ILD

Engaging Patients with MS and the Care Team in Shared Decision-Making

Advances in MS Assessment: Biomarkers and Imaging

Defining the Clinical Course of Multiple Sclerosis

Thrombotic Thrombocytopenic Purpura (TTP) Podcasts

Innovating Diabetes Care: Use of Real-Time Data

The Safety of Hemophilia Gene Therapy Now and in the Future

Viral Vectors Gene Therapy Podcasts

WFH Gene Therapy Registry

HTC Readiness: A Multidisciplinary Perspective

HTC Readiness: A Global Perspective

IPF Animated Video Series: Micro-learning focusing on the soft skills

SMA: Introduction and Key Concepts

Learnings From the Virtual ERS International Congress

Interstitial Pneumonia with Autoimmune Features (IPAF)

How to Identify & Manage Patients with Progressive-Fibrosing ILD

A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting

A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story

How Pulmonary Arterial Hypertension Has Changed Iain’s Life

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Molecular Diagnosis of Limb-Girdle Muscle Weakness